Mucosal Irritation Testing for Medical Dressings: Standards, Methods, and Regulatory Compliance

Mucosal irritation testing is an essential biocompatibility study for medical dressings that contact mucous membranes, breached skin, or wound surfaces during clinical use. Performed in accordance with ISO 10993-23 and the corresponding GB/T 16886.23 national standard, this test determines whether dressing extracts induce erythema, edema, or other local inflammatory responses in mucosal tissue. This article reviews the test principle, applicable dressings, experimental methodology, scoring criteria, and regulatory applications to support manufacturers in preparing compliant biological evaluation dossiers.

Technical Overview

The mucosal irritation test is an in vivo biocompatibility study designed to evaluate whether a medical dressing, or the chemical substances that migrate out of it, can provoke a local inflammatory reaction—principally erythema, edema, and eschar formation—after contact with mucous membranes. Within the biological evaluation framework of ISO 10993-1, irritation is a default endpoint for surface medical devices that contact intact mucosa, breached or compromised surfaces, or wounds, making the test highly relevant to many dressing categories.

Following the restructure of the ISO 10993 series, irritation testing was consolidated from ISO 10993-10 into ISO 10993-23 ("Biological evaluation of medical devices — Part 23: Tests for irritation"). In China, the equivalent national standard is GB/T 16886.23, which is harmonized with the ISO document and is routinely cited in registration dossiers submitted to the National Medical Products Administration. Sample preparation and extraction are governed by ISO 10993-12 and GB/T 16886.12.

The test principle is straightforward: the dressing is extracted under defined conditions in polar and non-polar media, and the resulting extracts are applied to appropriate mucosal sites in validated animal models, most commonly rabbits and Syrian hamsters. Treated sites are observed at prescribed intervals and scored against a standardized scale, and the reaction produced by the test extract is compared with that of the blank control to determine the irritation potential of the device.

• Evaluates local, reversible inflammatory responses rather than systemic toxicity
• Applies to devices with mucosal, breached-surface, or wound contact under ISO 10993-1 categorization
• Uses polar and non-polar extracts to cover both hydrophilic and lipophilic extractables
• Provides quantitative scoring that feeds directly into risk management documentation

Testing Samples

Conventional Woven and Non-Woven Dressings

Gauze swabs, absorbent cotton pads, non-woven wound dressings, adhesive plasters, and elastic bandages that may be applied to or near oral, nasal, or other mucosal sites fall within the scope of mucosal irritation evaluation. Although these products are generally regarded as chemically simple, the presence of bleaching residues, finishing agents, or adhesives can still justify testing.

Advanced Moist Wound Dressings

Hydrocolloid dressings, amorphous and sheet hydrogels, polyurethane and silicone foams, calcium alginate and carboxymethylcellulose fiber dressings, transparent film dressings, superabsorbent dressings, and silicone contact layers contain polymers, plasticizers, tackifiers, and crosslinking residues that can leach into tissue. Because many advanced dressings are indicated for compromised skin and cavity wounds with mucosal proximity, they are a primary category for mucosal irritation testing.

Antimicrobial and Drug-Containing Dressings

Dressings incorporating silver compounds, iodine species such as povidone-iodine or cadexomer iodine, polyhexamethylene biguanide (PHMB), medical-grade honey, or zinc oxide release biologically active agents at relatively high local concentrations. These elutable substances carry an elevated irritation concern, and regulatory reviewers frequently expect robust mucosal irritation data before clearing such claims.

Biological and Composite Dressings

Collagen sponges, alginate-collagen composites, chitosan-based materials, and tissue-derived products require careful assessment because residual processing chemicals, crosslinkers, and degradation products can all contribute to mucosal reactivity. Testing is typically performed on the final, sterilized product in its commercial packaging configuration.

Testing Items

The mucosal irritation program is selected according to the intended clinical contact site of the dressing. Standard test items and endpoints include the following:

• Oral mucosal irritation test, typically performed in the hamster cheek pouch model or on rabbit oral mucosa
• Vaginal mucosal irritation test, performed in the rabbit model
• Rectal mucosal irritation test, performed in the rabbit model
• Penile and urethral mucosal irritation test, where relevant to the intended use
• Erythema and eschar formation scoring on a 0 to 4 grading scale
• Edema scoring on a 0 to 4 grading scale
• Additional observations such as mucosal erosion, discharge, or blanching where present
• Optional histopathological examination of excised mucosal tissue to strengthen the conclusion
• General clinical observations and body weight monitoring throughout the study

Testing Methods

Sample Preparation and Extraction

Dressings are cut, weighed, or measured and extracted in accordance with ISO 10993-12. Polar extraction is performed with 0.9% sodium chloride injection, while non-polar extraction uses a vegetable oil such as cottonseed or sesame oil. Additional media, for example water or ethanol-in-water mixtures, may be justified when the material chemistry warrants it. For film-like dressings, an extraction ratio of 3 cm² per milliliter applies to samples up to 0.5 mm thick, and 6 cm² per milliliter for samples between 0.5 mm and 1 mm; absorbent and irregular products are typically dosed on a mass basis. The reference extraction condition is 37 °C ± 1 °C for 24 h ± 2 h, with accelerated alternatives of 50 °C for 72 h, 70 °C for 24 h, or 121 °C for 1 h when scientifically justified.

Test Procedure by Exposure Route

For the vaginal mucosal test in rabbits, a defined volume of test extract, typically 1 mL, is instilled into the vaginal vault once daily for five consecutive days for short-term devices, with extended ten-day schedules for prolonged contact claims. The oral mucosal test applies the extract to the hamster cheek pouch at controlled intervals, and the rectal test follows an analogous repeated-dose instillation protocol. Each study includes a blank control group treated only with the extraction medium, and positive control materials are validated periodically within the testing facility to confirm model sensitivity.

Observation and Scoring

Mucosal sites are examined at approximately 1 hour after each exposure and at 24, 48, and 72 hours after the final dose, with reactions graded for erythema and eschar formation and for edema on scales from 0 (no reaction) to 4 (severe reaction). Scoring is performed by trained observers under blind conditions where feasible, and the total reaction scores for each animal are recorded across all reading intervals.

Data Analysis and Interpretation

The Primary Irritation Index is calculated as the sum of all scores divided by the number of animals multiplied by the number of reading intervals, yielding a maximum value of 8. The test article is judged acceptable when the reaction observed with the test extract is not significantly greater than that produced by the corresponding blank control. For reporting purposes, irritation indices are commonly categorized as follows:

• 0.0 to 0.4 — negligible irritation
• 0.5 to 1.9 — slight irritation
• 2.0 to 4.9 — moderate irritation
• 5.0 to 8.0 — severe irritation

The final report documents sample description, extraction parameters, animal procedures, individual and mean scores, control comparison, and a conclusion on the mucosal irritation potential of the dressing in its clinical configuration.

Applications

Mucosal irritation test reports serve multiple regulatory and developmental purposes across the product lifecycle:

• Biological evaluation chapters of medical device registration dossiers for wound dressing products submitted to national regulatory authorities
• Premarket submissions in major jurisdictions, including 510(k) notifications in the United States and CE technical documentation under the European Medical Device Regulation
• Supporting evidence when manufacturers make justified claims of biocompatibility for dressings applied to mucosal surfaces or cavity wounds
• Re-evaluation following material changes, formulation changes, supplier changes, sterilization method changes, or primary packaging changes
• Research and development screening to compare candidate materials, coatings, and antimicrobial loadings before clinical study investment
• Quality and tender documentation demonstrating conformity with recognized biocompatibility standards

FAQ

Which medical dressings require mucosal irritation testing?

Testing is indicated for any dressing whose intended use involves contact with intact mucous membranes, breached or compromised surfaces, or wounds in mucosal proximity, such as nasal packs, oral dressings, perineal and sacral dressings, and cavity-filling products. Under the risk-based approach of ISO 10993-1, the decision also considers contact duration and the chemical nature of the materials involved.

Which standards govern mucosal irritation testing?

The primary standard is ISO 10993-23, which supersedes the irritation provisions formerly located in ISO 10993-10. In China, GB/T 16886.23 is the equivalent national standard. Sample preparation follows ISO 10993-12 and GB/T 16886.12, while the overall evaluation strategy is framed by ISO 10993-1 and GB/T 16886.1.

What animal models are used?

New Zealand white rabbits are the standard model for vaginal, rectal, and penile mucosal irritation, while Syrian golden hamsters are preferred for the cheek pouch model of oral mucosal irritation. Species and route selection must match the clinical contact site of the device.

How long does a typical study take?

Exposure phases generally run five to ten days depending on the route and intended contact duration, followed by a post-exposure observation window of up to 72 hours. Including acclimatization, extraction, and reporting, most mucosal irritation studies are completed within four to eight weeks.

What sample quantities and condition are required?

Testing should be performed on the final product in its sterilized, commercial form. Accredited third-party laboratories typically request finished dressings sufficient to provide the required extraction surface area or mass for both polar and non-polar media, along with duplicates and reserve material, all accompanied by lot information and handling instructions.

Can in vitro methods replace the animal test?

In vitro alternatives such as reconstructed human epithelium models are increasingly used for screening and, for certain endpoints such as ocular irritation, may support the overall assessment. However, regulatory acceptance of full replacement is still evolving, and in vivo mucosal irritation studies under ISO 10993-23 remain the reference approach for most dressing registrations unless a validated alternative is justified within the biological evaluation plan.

What distinguishes mucosal irritation testing from skin irritation testing?

Both tests use similar scoring principles, but they evaluate different tissue types and exposure routes. Skin irritation, also covered by ISO 10993-23, is performed on rabbit skin with dermal patch application, whereas mucosal irritation applies extracts directly to mucosal surfaces using route-specific protocols. Mucosa is generally more permeable and more sensitive, so a dressing that passes skin testing may still require dedicated mucosal data when mucosal contact is intended.